QuickView for AP-1;jsessionid=7D462474581831C49D1DF20533DC7907;jsessionid=590F8D000A7821D1EDE6F5B95F6ACC4F;jsessionid=CCE9CDFA517982CF09EC8DA841527D7B;jsessionid=E17BF29E09B585321F881DF8FACC18EF;jsessionid=5B7CDBB66DE325AB6757F502F0D349BA (gene)

1. c-JUN is a barrier in hESC to cardiomyocyte transition.
2. Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replicati…
3. Targeting c-Jun Is a Potential Therapy for Luminal Breast Cancer Bone Metastasis.
4. PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development.
5. Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study.

There were no clinical trials for AP-1;jsessionid=7D462474581831C49D1DF20533DC7907;jsessionid=590F8D000A7821D1EDE6F5B95F6ACC4F;jsessionid=CCE9CDFA517982CF09EC8DA841527D7B;jsessionid=E17BF29E09B585321F881DF8FACC18EF;jsessionid=5B7CDBB66DE325AB6757F502F0D349BA